Animal models of invasive aspergillosis for drug discovery
- 1 September 2014
- journal article
- review article
- Published by Elsevier in Drug Discovery Today
- Vol. 19 (9) , 1380-1386
Abstract
No abstract availableKeywords
This publication has 60 references indexed in Scilit:
- A controlled study to determine the efficacy of Loxostylis alata (Anacardiaceae) in the treatment of aspergillus in a chicken (Gallus domesticus) model in comparison to ketoconazoleBMC Veterinary Research, 2012
- Detection and Measurement of Fungal Burden in a Guinea Pig Model of Invasive Pulmonary Aspergillosis by Novel Quantitative Nested Real-Time PCR Compared with Galactomannan and (1,3)-β- d -Glucan DetectionJournal of Clinical Microbiology, 2012
- Inbred Strains Should Replace Outbred Stocks in Toxicology, Safety Testing, and Drug DevelopmentToxicologic Pathology, 2010
- High‐throughput screening and small animal models, where are we?British Journal of Pharmacology, 2010
- Pathogenesis ofAspergillus fumigatusin Invasive AspergillosisClinical Microbiology Reviews, 2009
- Combination Therapy in Treatment of Experimental Pulmonary Aspergillosis: In Vitro and In Vivo Correlations of the Concentration- and Dose- Dependent Interactions between Anidulafungin and Voriconazole by Bliss Independence Drug Interaction AnalysisAntimicrobial Agents and Chemotherapy, 2009
- BioluminescentAspergillus fumigatus, a New Tool for Drug Efficiency Testing and In Vivo Monitoring of Invasive AspergillosisApplied and Environmental Microbiology, 2008
- Assessment of Aspergillus fumigatus Burden in Pulmonary Tissue of Guinea Pigs by Quantitative PCR, Galactomannan Enzyme Immunoassay, and Quantitative CultureAntimicrobial Agents and Chemotherapy, 2008
- Aspergillus fumigatus: Principles of Pathogenesis and Host DefenseEukaryotic Cell, 2007
- The origins and uses of mouse outbred stocksNature Genetics, 2005